Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
暂无分享,去创建一个
D. Juric | B. Sikic | P. O'dwyer | E. Paietta | J. Racevskis | J. Rowe | A. Goldstone | N. Lacayo | P. Wiernik | Meghan C. Ramsey
[1] Quynh-Thu Le,et al. Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.
[2] Hongyue Dai,et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[3] Eivind Hovig,et al. Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling , 2006, Nucleic acids research.
[4] M. Tallman,et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. , 2005, Blood.
[5] Robert Gentleman,et al. Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation , 2005, Clinical Cancer Research.
[6] T. Cotter,et al. Bcr‐Abl regulates osteopontin transcription via Ras, PI‐3K, aPKC, Raf‐1, and MEK , 2005, Journal of leukocyte biology.
[7] B Johansson,et al. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations , 2005, Leukemia.
[8] R. Foà,et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. , 2005, Blood.
[9] Karen Blyth,et al. The runx genes: gain or loss of function in cancer , 2005, Nature Reviews Cancer.
[10] R. Offringa,et al. SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity. , 2005, Blood.
[11] Gavin Sherlock,et al. The Stanford Microarray Database accommodates additional microarray platforms and data formats , 2004, Nucleic Acids Res..
[12] Ping Chen,et al. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. , 2004, Journal of medicinal chemistry.
[13] C. Heldin,et al. Suppressors of T-cell Receptor Signaling Sts-1 and Sts-2 Bind to Cbl and Inhibit Endocytosis of Receptor Tyrosine Kinases* , 2004, Journal of Biological Chemistry.
[14] T. Fujita,et al. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling , 2004, The Journal of cell biology.
[15] G. Gatta,et al. Adult acute lymphoblastic leukaemia. , 2004, Critical reviews in oncology/hematology.
[16] J. Ruidavets,et al. Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. , 2004, Cancer research.
[17] A. Steinkasserer,et al. The soluble form of CD83 is present at elevated levels in a number of hematological malignancies. , 2004, Leukemia research.
[18] J. Harbott,et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. , 2004, Blood.
[19] T. McDonnell,et al. Transcriptional Regulation of bcl-2 Mediated by the Sonic Hedgehog Signaling Pathway through gli-1* , 2004, Journal of Biological Chemistry.
[20] A. Callegaro,et al. Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia , 2003, Leukemia.
[21] W. Williams,et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. , 2003, Blood.
[22] A. Kitzis,et al. Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl , 2003, Oncogene.
[23] W. Hiddemann,et al. Molecular characterization of acute leukemias by use of microarray technology , 2003, Genes, chromosomes & cancer.
[24] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] F. Salvatore,et al. BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations , 2002, Oncogene.
[26] E. Nishida,et al. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway , 2002, Nature Cell Biology.
[27] Russ B. Altman,et al. Nonparametric methods for identifying differentially expressed genes in microarray data , 2002, Bioinform..
[28] J. Bourhis,et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial. , 2002, Blood.
[29] Anjali S Advani,et al. Bcr-Abl variants: biological and clinical aspects. , 2002, Leukemia research.
[30] A. Keegan,et al. Overexpression of Insulin Receptor Substrate-1, But Not Insulin Receptor Substrate-2, Protects a T Cell Hybridoma from Activation-Induced Cell Death1 , 2002, The Journal of Immunology.
[31] H. Iwasaki,et al. Critical role for Gab2 in transformation by BCR/ABL. , 2002, Cancer cell.
[32] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Downing,et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.
[34] T. Lipp,et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. , 2002, Blood.
[35] S. Dudoit,et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.
[36] S. Mane,et al. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2. , 2002, Blood.
[37] D. Mousseau,et al. PILRα, a Novel Immunoreceptor Tyrosine-based Inhibitory Motif-bearing Protein, Recruits SHP-1 upon Tyrosine Phosphorylation and Is Paired with the Truncated Counterpart PILRβ* , 2000, The Journal of Biological Chemistry.
[38] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Stark,et al. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Neuberg,et al. Expression of CD25 (interleukin-2 receptor α chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993 , 1997, Leukemia.
[41] W. Prensky,et al. Dendritic nucleic acid structures. , 1997, Journal of theoretical biology.
[42] J. Melo,et al. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. , 1996, Blood.
[43] E. Estey,et al. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. , 1991, Blood.
[44] G. Paolucci,et al. [Treatment of acute lymphoblastic leukemia]. , 1971, Minerva pediatrica.
[45] R. Foà,et al. The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial. , 2006, Haematologica.
[46] W Hiddemann,et al. Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients , 2004, Leukemia.
[47] E. Lander,et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.
[48] D. Mousseau,et al. PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta. , 2000, The Journal of biological chemistry.
[49] D. Neuberg,et al. Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group/Medical Research Council. , 1997, Leukemia.